Harrow Inc (HROW) Live Share Price, Invest From India

Harrow Inc Stock Performance

as on January 10, 2026 at 2:29 am IST

Day's Low
Day's High
$46.54
Day's Price Range
$51.06
$46.84
0.64%
Downside
9.01%
Upside
52 Week's Low
52 Week's High
$20.85
52-Week Price Range
$54.85
$46.84
55.49%
Downside
17.10%
Upside

Harrow Inc share price movements today

Previous Close: $51.04
Open: $51.00
Volume: 873.2K
Day's Low - High: $46.54 - $51.06
52 Week Low - High: $20.85 - $54.85

Harrow Inc Historical Returns

1 Month Return: -6.81 %
3 Month Return: + 24.81 %
1 Year Return: + 27.57 %
3 Year Return: + 228.51 %
5 Year Return: 0 %

Harrow Inc Stock Fundamentals & Key Indicators

Check Harrow Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

0.6167

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.64%

PE Ratio (TTM)

PEG Ratio

EBITDA

46.1M

Revenue (TTM)

250.0M

Profit Margin

-2.00%

Return On Equity TTM

-9.57%

Harrow Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harrow Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Harrow Inc	BUY	$1.9B	NA	NA	-2.00%
Regencell Bioscience Holdings Ltd	NA	$20.5B	NA	NA	0.00%
United Therapeutics Corporation	BUY	$21.9B	NA	18.33	40.65%
Haleon Plc Spon Ads	BUY	$44.7B	NA	22.31	13.81%
Viatris Inc.	HOLD	$14.5B	-30.27%	-21.95	-26.13%

See all

Stock Returns calculator for Harrow Inc Stock including INR - Dollar returns

The Harrow Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Harrow Inc investment value today

Current value as on today

₹1,32,345

Returns

₹32,345

(+32.35%)

Returns from Harrow Inc Stock

₹27,734 (+27.73%)

Dollar Returns*

₹4,612 (+4.61%)

Analyst Recommendation on Harrow Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Harrow Inc. Average target price of $70.62

Harrow Inc Share Price Target

Get share price movements and forecasts by analysts on Harrow Inc.

What analysts predicted

33.67%UPSIDE

Target Price

$70.62

Current Price

$46.84

Analyzed by

10 Analysts

Target

$70.62

Harrow Inc target price $70.62, a slight upside of 33.67% compared to current price of $46.84. According to 10 analysts rating.

Harrow Inc Stock’s Investor Sentiment and Interest

Search interest for Harrow Inc Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: December 12, 2025 to January 11, 2026

Change:-56% versus previous 30 day period

Harrow Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	33	34	36	34	48	49	66	47	63	71
Gross Profit	23	24	25	24	36	37	52	32	47	53
Operating Income	2	1	-4	-6	1	1	12	-11	11	14
EBITDA	5	4	-1	-4	4	4	17	-6	15	11
Interest Expense	5	5	5	5	5	5	6	6	6	6
Depreciation	3	3	3	3	3	3	4	4	4	4
Income Before Tax	-4	-2	-9	-13	-5	-4	6	-17	4	1
Income Tax Expense	0	1	0	3	0	0	0	-	-	-
Net Income	-4	-4	-9	-13	-6	-4	6	-17	4	1
Net Profit Margin	-12.64%	-12.81%	-25.16%	-39.22%	-13.23%	-8.57%	10.14%	-37.17%	7.84%	1.42%

Harrow Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	9	19	26	41	51	48	72	88	130	199
Gross Profit	4	10	13	24	34	34	54	63	90	150
Operating Income	-14	-15	-12	-5	-4	0	1	1	0	8
EBITDA	-14	-14	-10	-3	1	2	5	4	11	22
Interest Expense	1	2	3	2	2	2	5	7	21	22
Depreciation	-	-	1	1	2	2	2	3	12	14
Income Before Tax	-15	-19	-12	14	0	-3	-17	-14	-23	-17
Income Tax Expense	1	0	0	-19	0	0	0	0	0	0
Net Income	-15	-19	-11	14	0	-3	-18	-14	-24	-17
Net Profit Margin	-163.64%	-95.71%	-44.76%	35.35%	0.33%	-6.87%	-24.85%	-15.90%	-18.75%	-8.76%

Harrow Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-4	-9	-13	-6	-4	6	-17	4	1
Operating Cash Flow	-1	8	-4	-2	2	-17	19	0	16
Investing Cash Flow	-20	0	0	5	0	-37	0	0	0
Financing Cash Flow	64	0	0	0	0	29	0	-12	4
Change in Cash	42	8	-5	2	1	-25	19	-13	21

Harrow Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-11	14	0	-3	-18	-14	-24	-17
Operating Cash Flow	-11	-8	0	0	-1	5	1	3	-22
Investing Cash Flow	-7	0	-2	-1	0	-18	-1	-152	-33
Financing Cash Flow	24	4	4	-1	1	51	54	126	28
Change in Cash	6	-4	2	-1	0	37	54	-22	-26

Global Institutional Holdings in Harrow Inc

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0.99%
D. E. Shaw & Co LP	0.56%
Private Capital Management, LLC	5.26%
Vanguard Group Inc	5.05%
Citadel Advisors Llc	1.81%

See all

Insights on Harrow Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 47.83M → 71.63M (in $), with an average increase of 18.0% per quarter
NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 6037.2% return, outperforming this stock by 5805.7%
NO EFFECT
Against Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 35898.4% return, outperforming this stock by 35870.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, HROW stock has moved down by -6.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 4.99M → 1.02M (in $), with an average decrease of 79.6% per quarter

About Harrow Inc

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas

Organisation	Harrow Inc
Headquarters	1A Burton Hills Boulevard, Nashville, TN, United States, 37215
Industry	Health Technology
CEO	Mr. Mark L. Baum J.D.
E-voting on shares	Click here to vote

Key Management of Harrow Inc

Name	Title
Dr. Amir W. Shojaei Ph.D., Pharm.D.	Chief Scientific Officer
Mr. Michael D. Biega	Vice President of Investor Relations & Communications
Mr. Brett A. Burrell	Vice President of Legal & Compliance
Ms. Kim Barratt	Chief Talent Officer
Dr. Prashanth S. Annavajjhala	Chief of Staff
Mr. Andrew R. Boll C.F.A., C.M.A.	President, CFO & Corporate Secretary
Mr. Randall E. Pollard	Chief Accounting Officer
Dr. Mark A. Mannebach Ph.D., R.Ph.	Head of Regulatory Affairs & Pharmacovigilance
Mr. Greg DiPasquale	Senior VP & Head of Commercial
Mr. Mark L. Baum J.D.	CEO & Chairman of the Board

FAQs

What is Harrow Inc share price today?

Harrow Inc share price today is $46.84 as on January 10, 2026 at 2:29 am IST at the close of the market. Harrow Inc share today touched a day high of $51.06 and a low of $46.54.

What is the 52 week high and 52 week low for Harrow Inc share?

Harrow Inc share touched a 52 week high of $54.85 on January 7, 2026 and a 52 week low of $20.85 on April 9, 2025. Harrow Inc stock price today i.e. January 10, 2026 at 2:29 am IST is closed at $46.84,which is 14.60% down from its 52 week high and 124.65% up from its 52 week low.

What is Harrow Inc's market capitalisation today?

Harrow Inc market capitalisation is $0.00T as on January 10, 2026 at 2:29 am IST.

How to invest in Harrow Inc Stock (HROW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Harrow Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Harrow Inc Shares that will get you 0.0320 shares as per Harrow Inc share price of $46.84 per share as on January 10, 2026 at 2:29 am IST.

What is the minimum amount required to buy Harrow Inc Stock (HROW) from India?

Indian investors can start investing in Harrow Inc (HROW) shares with as little as ₹90.17 or $1 (as of January 11, 2026 at 6:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹901.70 in Harrow Inc stock (as per the Rupee-Dollar exchange rate as on January 11, 2026 at 6:38 am IST). Based on Harrow Inc share’s latest price of $46.84 as on January 10, 2026 at 2:29 am IST, you will get 0.2135 shares of Harrow Inc. Learn more about fractional shares .